PortViewPortView
HTG Molecular Diagnostics logo

HTG Molecular Diagnostics (HTGM) Stock Analysis

NASDAQHealthcareMedical - Diagnostics & Research

$0.48+0.00%
1-year price historyRange $0.48 – $22.68
52-week range$0.48
$0.46$24.96

What HTG Molecular Diagnostics does

Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targets. Their extensive portfolio features numerous molecular profiling panels, such as the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay (available in both EU and non-EU versions), HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq ALKPlus assay EU, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG immune response panel, and HTG mouse mRNA tumor response panel. The company directly distributes its instruments and consumables across the United States and Europe, while utilizing distributors for other international markets and specific European regions. Their diverse clientele includes biopharmaceutical companies, academic research centers, and molecular testing laboratories. Additionally, HTG Molecular Diagnostics, Inc. maintains a governing agreement with QIAGEN Manchester Limited. The company was founded in 1997 as HTG, Inc., and officially changed its name to HTG Molecular Diagnostics, Inc. in March 2011.

Key metrics

Market cap
$1.06M
P/E (TTM)
-0.03
EPS (TTM)
$-17.10
Beta
0.99
Dividend yield
0.00%
Revenue / share
$7.16
50-day avg
$2.33
200-day avg
$4.75
52-week high
$24.96
52-week low
$0.46
CEO
John L. Lubniewski

ETFs linked to HTGM

Broad-market and Healthcare sector ETFs an investor holding HTG Molecular Diagnostics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HTGM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HTGM in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for HTG Molecular Diagnostics?
HTG Molecular Diagnostics trades under the ticker HTGM on NASDAQ.
Which exchange is HTGM listed on?
HTGM is listed on NASDAQ.
What sector does HTG Molecular Diagnostics operate in?
HTG Molecular Diagnostics is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
How can PortView help analyze HTGM in a portfolio?
PortView shows HTGM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.